Brief: China Pioneer Pharma Holdings says entered into agreement to dispose 100% interest in subsidiary
Oct 17 (Reuters) - China Pioneer Pharma Holdings Ltd
1345.HK :
* Deal for consideration of rmb158.4 million
* Company estimates that group will record an unaudited gain
of approximately rmb8.9 million from disposal
* Unit entered into agreement with li to purchase sale
share, representing entire issued share capital of target co
* Seller being pioneer pharma (hong kong) co
Source text for Eikon: ID:nHKS7pHV3w
Further company coverage: 1345.HK
((Bangalore.newsroom@thomsonreuters.com ;))
Recent news on Shanghai Pioneer Holding
See all newsBrief: Shanghai Pioneer Posts HY Revenue Rmb602.8 Million
Brief: Shanghai Pioneer Net Profit Rmb105.1 Million In 2025
Brief: Shanghai Pioneer To Be Exclusive Distributor Of Labo Hair Loss Vials In China
Brief: Shanghai Pioneer Logs H1 Gross Profit RMB 303 Mln
Brief: Shanghai Pioneer Expects 45%-48% Net Profit Decrease For HY